CIK 0001759655 · Large accelerated filer
Privia Health Group, Inc.
Sign in to watch- Ticker
- PRVA
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 571-366-8850
- Business address
- 950 N. GLEBE RD., SUITE 700, ARLINGTON, VA, 22203
- Former names
- PH Group Parent Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-26 | Morris Matthew Shawn Director | Option exercise 10b5-1 | +88,110 | $2.00 | $176K | 164,761 |
| 2026-06-26 | Morris Matthew Shawn Director | Sale 10b5-1 | −88,110 | $25.33 | $2.2M | 76,651 |
| 2026-06-26 | Morris Matthew Shawn Director | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −88,110 | 3,586,091 | ||
| 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise 10b5-1 | +17,196 | $2.00 | $34K | 228,658 |
| 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | Sale 10b5-1 | −17,196 | $25.18 | $433K | 211,462 |
| 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −5,962 | 0 | ||
| 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,001 | 0 | ||
| 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −1,336 | 0 | ||
| 2026-06-26 | Mountcastle David EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Purchase) 10b5-1 | −8,897 | 0 | ||
| 2026-05-20 | SOISTMAN FRANCIS S JR Director | Grant or award | +8,463 | 8,463 | ||
| 2026-05-20 | BERBERIAN LANCE Director | Grant or award | +8,463 | 16,131 | ||
| 2026-05-20 | COCOZZA NANCY G Director | Grant or award | +8,463 | 42,814 | ||
| 2026-05-20 | Kimmet Pamela O Director | Grant or award | +8,463 | 34,172 | ||
| 2026-05-20 | McCarthy Thomas A Director | Grant or award | +8,463 | 27,983 | ||
| 2026-05-20 | Morris Matthew Shawn Director | Grant or award | +8,463 | 76,651 | ||
| 2026-05-20 | Ryu Jaewon Director | Grant or award | +8,463 | 47,110 | ||
| 2026-05-20 | KING DAVID P Director | Grant or award | +8,463 | 50,775 | ||
| 2026-05-12 | Mehrotra Parth Chief Executive Officer | Sale 10b5-1 | −15,647 | $22.64 | $354K | 434,357 |
| 2026-05-11 | Mountcastle David EVP & Chief Financial Officer | Sale | −3,385 | $22.60 | $77K | 211,462 |
| 2026-05-11 | Mehrotra Parth Chief Executive Officer | Sale 10b5-1 | −105,439 | $22.55 | $2.4M | 450,004 |
Page 2 of 11 · 214 trades